pharmaceutical investing Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
pharmaceutical investing Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting
pharmaceutical investing Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress
pharmaceutical investing Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid Injectables with JUVÉDERM® at AMWC Monaco
pharmaceutical investing Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
pharmaceutical investing New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row
pharmaceutical investing AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
pharmaceutical investing AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® Subcutaneous Induction in Patients with Crohn's Disease
pharmaceutical investing AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States
pharmaceutical investing U.S. Food and Drug Administration Approves Combination Treatment of VENCLEXTA® and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia
